Clinical Trials for Mitomycin-C

1 Open Trial

Trial TypeProtocol No. &
Open Date
An Integrated Phase II/III Open Label, Randomized, Parallel and Controlled Study of the Safety and Efficacy of CG0070 Oncolytic Vector Regimen in Patients with Non-Muscle Invasive Bladder Carcinoma in Situ Disease ("NMIBCis", Meaning CIS and CIS with Ta and/or T1) and Who Have Failed BCG Therapy and Refused Cystectomy

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.